title: Selectively bred crossed high-alcohol-preferring mice drink to intoxication and develop functional tolerance, but not locomotor sensitization during free-choice ethanol access.
abstract: BACKGROUND
  Crossed high-alcohol-preferring (cHAP) mice were selectively bred from a cross of the HAP1 × HAP2 replicate lines and demonstrate blood ethanol concentrations (BECs) during free-choice drinking reminiscent of those observed in alcohol-dependent humans. In this report, we investigated the relationship between free-choice drinking, intoxication, tolerance, and sensitization in cHAP mice. We hypothesized that initially mice would become ataxic after drinking alcohol, but that increased drinking over days would be accompanied by increasing tolerance to the ataxic effects of ethanol (EtOH).
  
  
  METHODS
  Male and female cHAP mice had free-choice access to 10% EtOH and water (E), while Water mice (W) had access to water alone. In experiment 1, the first drinking experience was monitored during the dark portion of the cycle. Once E mice reached an average intake rate of ≥1.5 g/kg/h, they, along with W mice, were tested for footslips on a balance beam, and BECs were assessed. In experiments 2, 3, and 4, after varying durations of free-choice 10% EtOH access (0, 3, 14, or 21 days), mice were challenged with 20% EtOH and tested for number of footslips on a balance beam or locomotor stimulant response. Blood was sampled for BEC determination.
  
  
  RESULTS
  We found that cHAP mice rapidly acquire alcohol intakes that lead to ataxia. Over time, cHAP mice developed behavioral tolerance to the ataxic effects of alcohol, paralleled by escalating alcohol consumption. However, locomotor sensitization did not develop following 14 days of free-choice EtOH access.
  
  
  CONCLUSIONS
  Overall, we observed increases in free-choice drinking with extended alcohol access paralleled by increases in functional tolerance, but not locomotor sensitization. These data support our hypothesis that escalating free-choice drinking over days in cHAP mice is driven by tolerance to alcohol's behavioral effects. These data are the first to demonstrate that escalating free-choice consumption is accompanied by increasing alcohol tolerance. In addition to buttressing the hypothesized importance of tolerance in drinking, our findings suggest that cHAP mice may be a unique, translational resource for studying tolerance as a contributor to and consequence of chronic, excessive EtOH consumption.
authors.affiliation: Department of Psychology , IUPUI, Indianapolis, Indiana.
authors.forename: Liana M
authors.initials: LM
authors.lastname: Matson
authors.forename: Chelsea R
authors.initials: CR
authors.lastname: Kasten
authors.forename: Stephen L
authors.initials: SL
authors.lastname: Boehm
authors.forename: Nicholas J
authors.initials: NJ
authors.lastname: Grahame
mesh_terms: D000428:Alcohol Drinking / Q000235:genetics* / Q000503:physiopathology / Q000523:psychology; D000435:Alcoholic Intoxication / Q000235:genetics* / Q000503:physiopathology / Q000523:psychology; D000818:Animals; D002755:Choice Behavior / Q000187:drug effects* / Q000502:physiology; D000431:Ethanol / Q000008:administration & dosage* / Q000633:toxicity; D005260:Female; D006824:Hybridization, Genetic; D008297:Male; D051379:Mice; D009043:Motor Activity / Q000187:drug effects* / Q000502:physiology
chemical_list: D000431:Ethanol
keywords: Alcohol Consumption; Motor Ataxia; Rodent Model; Selected Line; Tolerance
references.citation: Alcohol Clin Exp Res. 1994 Aug;18(4):931-41
references.pmid: 7978106
references.citation: Behav Genet. 2010 Nov;40(6):737-50
references.pmid: 20552264
references.citation: Psychopharmacology (Berl). 1998 Feb;135(4):374-82
references.pmid: 9539262
references.citation: J Pharmacol Exp Ther. 1970 May;173(1):101-16
references.pmid: 5442292
references.citation: Arch Gen Psychiatry. 2011 Apr;68(4):389-99
references.pmid: 21464363
references.citation: Psychol Rev. 1991 Jul;98(3):390-408
references.pmid: 1891524
references.citation: Addict Biol. 2013 Nov;18(6):921-9
references.pmid: 22126215
references.citation: Exp Clin Psychopharmacol. 1999 Aug;7(3):234-43
references.pmid: 10472511
references.citation: Pharmacol Biochem Behav. 2007 Nov;88(1):105-13
references.pmid: 17698181
references.citation: Addict Biol. 2010 Apr;15(2):109-24
references.pmid: 20148775
references.citation: Pharmacol Biochem Behav. 1996 Mar;53(3):585-91
references.pmid: 8866959
references.citation: Psychopharmacology (Berl). 2008 Dec;201(2):249-60
references.pmid: 18685830
references.citation: Genes Brain Behav. 2013 Feb;12(1):78-86
references.pmid: 22853703
references.citation: Addiction. 2000 Aug;95 Suppl 2:S91-117
references.pmid: 11002906
references.citation: Pharmacol Biochem Behav. 1982 Jan;16(1):125-30
references.pmid: 7199181
references.citation: Alcohol Clin Exp Res. 2013 Feb;37(2):194-201
references.pmid: 22757960
references.citation: Alcohol Clin Exp Res. 1988 Feb;12(1):184-6
references.pmid: 2964796
references.citation: J Appl Physiol (1985). 2003 Oct;95(4):1338-51
references.pmid: 12704090
references.citation: Genes Brain Behav. 2007 Feb;6(1):1-18
references.pmid: 17233637
references.citation: Alcohol Clin Exp Res. 1991 Jun;15(3):399-405
references.pmid: 1877726
references.citation: Psychopharmacology (Berl). 2000 Aug;151(2-3):252-60
references.pmid: 10972472
references.citation: J Psychopharmacol. 2002 Mar;16(1):79-83
references.pmid: 11949776
references.citation: Alcohol Clin Exp Res. 1995 Apr;19(2):269-78
references.pmid: 7625557
references.citation: Alcohol Clin Exp Res. 2011 Jul;35(7):1246-55
references.pmid: 21410484
references.citation: Psychopharmacology (Berl). 2008 Apr;197(2):191-201
references.pmid: 18049811
references.citation: J Psychopharmacol. 1998;12(1):49-53
references.pmid: 9584968
references.citation: Pharmacol Biochem Behav. 1986 Nov;25(5):1013-20
references.pmid: 3786353
references.citation: Behav Genet. 2011 Mar;41(2):288-302
references.pmid: 20853157